Letter of Authorization: COVID-19 Airway Management Isolation Chamber | NLM

Disaster Information Management Research Center | NLM

Letter of Authorization: COVID-19 Airway Management Isolation Chamber

06/22/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 6/22/2020. This seven-page letter, updated on June 22, 2020, authorizes the emergency use of the COVID-19 Airway Management Isolation Chamber. This device is authorized for use by healthcare providers (HCP) as an extra layer of barrier protection in addition to personal protective equipment (PPE) to prevent HCP exposure to pathogenic biological airborne particulates during transport of patients, at the time of definitive airway management, or when performing medical procedures on such patients during the COVID-19 pandemic. (PDF)